Diagenic,Maybe one of the best Invest 2008
Diagenic will be one of the winner on the stock markets 2008!
DiaGenic ASA is in the process of commercialisation for their two first
diagnostic products; tests for breast cancer (BC) and Alzheimer’s
disease (AD). For BC the first revenues should be realised in second
half of 2008, following the commercial launch of the product in India.
Commercialisation of the AD test will continue in parallel, with first
revenues expected in 2009, after CE marking of the product.
EUROPEAN PATENT ALZHEIMER’S DISEASE
The patent when granted will be valid in 19 European countries and cover
the use of differentially expressed informative probes for diagnostic
purposes.
Diagenic will rise soon,My advice Invest you money
in next week ! Maybe one of the best Invest you can do for 2008.
oslo Stock Exchange
http://www.euroland.com
http://www.diagenic.com/
Hot Trigger:
EBCC-6 (European Breast Cancer Conference
Berlin, Germany - 15-19 April
Trigger:
1) 12-19/4: American Academy of Neurology, Chicago, IL, USA.
2) 15-19/4: EBCC-6, Berlin, Germany.
3) 19-21/5: Biomarker World congress, Philadelphia, PA, USA
4) 22-25/5: 18th Alzheimer Europe Conference, OSLO, NORWAY !
5) 30/5-3/6: American Society of Clinical Oncology, Chicago, IL, USA
6) 4-8/6: 5th World Conjference on Breast Cancer, Winnipeg, Canada.
7) 17-20/6: Bio 2008, San Diego, CA, USA.
Read this:
Oslo Stock Exchange
DiaGenic's shares are listed on the Oslo Stock Exchange under the ticker "DIAG
15.02.2008 Presentation of the fourth quarter 2007 report.
This stock will soon explode,you can buy it very cheap now in Oslo Stock Exchange!
A major breast cancer study in India that was set up by PAC Med Biotech on behalf of DiaGenic ASA is nearing completion on schedule. PAC Med Biotech is now coordinating the business entry of DiaGenic's blood-based breast cancer screening and diagnostic test through talks with major laboratory chains and pharmaceutical companies for a planned launch in mid 2008
The DiaGenic breast cancer blood test offers a unique range of advantages over existing methods. Firstly, the use of venous blood as the test-sample is patient friendly. The test also detects breast cancer in pre-menopausal women with good accuracy whereas mammography has major problems due to high breast density which obscures the mammographic image. This is especially important in India, where breast cancer is seen at a significantly lower age than in Western countries. Finally, the disease can be discovered at a very early stage, thus paving the way for effective intervention.
And this:
EUROPEAN PATENT ALZHEIMER’S DISEASE
Today DiaGenic received Notice of Allowance from European Patent Office
for its method of diagnosing Alzheimer’s disease using blood samples and
gene expression technology.
The patent when granted will be valid in 19 European countries and cover
the use of differentially expressed informative probes for diagnostic
purposes. The method of probe selection is general and not limited to
any one particular mode of selection. Earlier DiaGenic had received a
European patent, EP0979308, covering only the use of informative probes
isolated by non-sequence based methods for diagnostic purposes.
Also, DiaGenic has recently been notified by the Indian and Australian
Patent Authorities that they have accepted the claims comprising the use
of important gene sequences in the detection of, among others, breast
cancer and Alzheimer’s disease (parent application, PCT/GB03/005102).
MD PhD Erik Christensen, managing director of DiaGenic comments,“The
new European patent for diagnosis of Alzheimer’s disease is an important
milestone which strengthens our position in this region. The company
will now have similar patent protection in Europe and in the United
States. The growing patent portfolio reflects our active patent strategy
and confirms DiaGenic a leader in the field of molecular diagnostics
utilizing blood-based tests. The new patents also make DiaGenic an
attractive partner for a long period of time, since commercial
agreements are typically entered into for the lifetime of the patents”.
How to buy shares on the oslo stock exchange?
If your broker is any good this should be no problem. Just give him the full stock name and place the order. I believe there is very limited hours of trading, but again leave this to them. The usual problems are not in trading but in settlement, but again a good broker should have this covered.
The norwegian stock exchange is open to international investors, just go to any international bank and tell them which norwegian stocks you want to buy!